Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Human Monkeypox in Sierra Leone after 44-Year Absence of Reported Cases.

Reynolds MG, Wauquier N, Li Y, Satheshkumar PS, Kanneh LD, Monroe B, Maikere J, Saffa G, Gonzalez JP, Fair J, Carroll DS, Jambai A, Dafae F, Khan SH, Moses LM.

Emerg Infect Dis. 2019 May;25(5):1023-1025. doi: 10.3201/eid2505.180832. Epub 2019 May 17.

2.

HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2+ NK cells in Lassa virus infection.

Wauquier N, Petitdemange C, Tarantino N, Maucourant C, Coomber M, Lungay V, Bangura J, Debré P, Vieillard V.

EBioMedicine. 2019 Feb;40:605-613. doi: 10.1016/j.ebiom.2019.01.048. Epub 2019 Jan 30.

3.

Virus-encoded miRNAs in Ebola virus disease.

Duy J, Honko AN, Altamura LA, Bixler SL, Wollen-Roberts S, Wauquier N, O'Hearn A, Mucker EM, Johnson JC, Shamblin JD, Zelko J, Botto MA, Bangura J, Coomber M, Pitt ML, Gonzalez JP, Schoepp RJ, Goff AJ, Minogue TD.

Sci Rep. 2018 Apr 24;8(1):6480. doi: 10.1038/s41598-018-23916-z.

4.

Revisiting Ebola, a quiet river in the heart of Africa.

Gonzalez JP, Wauquier N, Vincent T.

Med Sante Trop. 2018 Feb 1;28(1):12-17. doi: 10.1684/mst.2018.0751.

5.

Contact tracing performance during the Ebola virus disease outbreak in Kenema district, Sierra Leone.

Senga M, Koi A, Moses L, Wauquier N, Barboza P, Fernandez-Garcia MD, Engedashet E, Kuti-George F, Mitiku AD, Vandi M, Kargbo D, Formenty P, Hugonnet S, Bertherat E, Lane C.

Philos Trans R Soc Lond B Biol Sci. 2017 May 26;372(1721). pii: 20160300. doi: 10.1098/rstb.2016.0300.

6.

Serosurveillance of viral pathogens circulating in West Africa.

O'Hearn AE, Voorhees MA, Fetterer DP, Wauquier N, Coomber MR, Bangura J, Fair JN, Gonzalez JP, Schoepp RJ.

Virol J. 2016 Oct 3;13(1):163.

7.

Circulating microRNA profiles of Ebola virus infection.

Duy J, Koehler JW, Honko AN, Schoepp RJ, Wauquier N, Gonzalez JP, Pitt ML, Mucker EM, Johnson JC, O'Hearn A, Bangura J, Coomber M, Minogue TD.

Sci Rep. 2016 Apr 21;6:24496. doi: 10.1038/srep24496.

8.

Longitudinal Analysis of Natural Killer Cells in Dengue Virus-Infected Patients in Comparison to Chikungunya and Chikungunya/Dengue Virus-Infected Patients.

Petitdemange C, Wauquier N, Devilliers H, Yssel H, Mombo I, Caron M, Nkoghé D, Debré P, Leroy E, Vieillard V.

PLoS Negl Trop Dis. 2016 Mar 3;10(3):e0004499. doi: 10.1371/journal.pntd.0004499. eCollection 2016 Mar.

9.

Animal Model of Sensorineural Hearing Loss Associated with Lassa Virus Infection.

Yun NE, Ronca S, Tamura A, Koma T, Seregin AV, Dineley KT, Miller M, Cook R, Shimizu N, Walker AG, Smith JN, Fair JN, Wauquier N, Bockarie B, Khan SH, Makishima T, Paessler S.

J Virol. 2015 Dec 30;90(6):2920-7. doi: 10.1128/JVI.02948-15.

10.

Understanding the emergence of ebola virus disease in sierra leone: stalking the virus in the threatening wake of emergence.

Wauquier N, Bangura J, Moses L, Humarr Khan S, Coomber M, Lungay V, Gbakie M, Sesay MS, Gassama IA, Massally JL, Gbakima A, Squire J, Lamin M, Kanneh L, Yillah M, Kargbo K, Roberts W, Vandi M, Kargbo D, Vincent T, Jambai A, Guttieri M, Fair J, Souris M, Gonzalez JP.

PLoS Curr. 2015 Apr 20;7. pii: ecurrents.outbreaks.9a6530ab7bb9096b34143230ab01cdef. doi: 10.1371/currents.outbreaks.9a6530ab7bb9096b34143230ab01cdef.

11.

Control of immunopathology during chikungunya virus infection.

Petitdemange C, Wauquier N, Vieillard V.

J Allergy Clin Immunol. 2015 Apr;135(4):846-55. doi: 10.1016/j.jaci.2015.01.039. Review.

PMID:
25843597
12.

Tactics and strategies for managing Ebola outbreaks and the salience of immunization.

Getz WM, Gonzalez JP, Salter R, Bangura J, Carlson C, Coomber M, Dougherty E, Kargbo D, Wolfe ND, Wauquier N.

Comput Math Methods Med. 2015;2015:736507. doi: 10.1155/2015/736507. Epub 2015 Feb 10.

13.

Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014.

Kuhn JH, Andersen KG, Baize S, Bào Y, Bavari S, Berthet N, Blinkova O, Brister JR, Clawson AN, Fair J, Gabriel M, Garry RF, Gire SK, Goba A, Gonzalez JP, Günther S, Happi CT, Jahrling PB, Kapetshi J, Kobinger G, Kugelman JR, Leroy EM, Maganga GD, Mbala PK, Moses LM, Muyembe-Tamfum JJ, N'Faly M, Nichol ST, Omilabu SA, Palacios G, Park DJ, Paweska JT, Radoshitzky SR, Rossi CA, Sabeti PC, Schieffelin JS, Schoepp RJ, Sealfon R, Swanepoel R, Towner JS, Wada J, Wauquier N, Yozwiak NL, Formenty P.

Viruses. 2014 Nov 24;6(11):4760-99. doi: 10.3390/v6114760.

14.

Long-term persistence of Chikungunya virus neutralizing antibodies in human populations of North Eastern Thailand.

Nitatpattana N, Kanjanopas K, Yoksan S, Satimai W, Vongba N, Langdatsuwan S, Nakgoi K, Ratchakum S, Wauquier N, Souris M, Auewarakul P, Gonzalez JP.

Virol J. 2014 Oct 21;11:183. doi: 10.1186/1743-422X-11-183.

15.

Association of HLA class-I and inhibitory KIR genotypes in Gabonese patients infected by Chikungunya or Dengue type-2 viruses.

Petitdemange C, Wauquier N, Jacquet JM, Theodorou I, Leroy E, Vieillard V.

PLoS One. 2014 Sep 29;9(9):e108798. doi: 10.1371/journal.pone.0108798. eCollection 2014.

16.

Control of acute dengue virus infection by natural killer cells.

Petitdemange C, Wauquier N, Rey J, Hervier B, Leroy E, Vieillard V.

Front Immunol. 2014 May 13;5:209. doi: 10.3389/fimmu.2014.00209. eCollection 2014. Review.

17.

Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus.

Yun NE, Seregin AV, Walker DH, Popov VL, Walker AG, Smith JN, Miller M, de la Torre JC, Smith JK, Borisevich V, Fair JN, Wauquier N, Grant DS, Bockarie B, Bente D, Paessler S.

J Virol. 2013 Oct;87(19):10908-11. doi: 10.1128/JVI.01433-13. Epub 2013 Jul 31.

18.

Risk factors for Zaire ebolavirus--specific IgG in rural Gabonese populations.

Nkoghe D, Padilla C, Becquart P, Wauquier N, Moussavou G, Akué JP, Ollomo B, Pourrut X, Souris M, Kazanji M, Gonzalez JP, Leroy E.

J Infect Dis. 2011 Nov;204 Suppl 3:S768-75. doi: 10.1093/infdis/jir344.

19.

Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity.

Petitdemange C, Becquart P, Wauquier N, Béziat V, Debré P, Leroy EM, Vieillard V.

PLoS Pathog. 2011 Sep;7(9):e1002268. doi: 10.1371/journal.ppat.1002268. Epub 2011 Sep 22.

20.

The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation.

Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiguino A, Leroy EM.

J Infect Dis. 2011 Jul 1;204(1):115-23. doi: 10.1093/infdis/jiq006. Epub 2010 Dec 14.

21.

Evidence for Ebola virus superantigen activity.

Leroy EM, Becquart P, Wauquier N, Baize S.

J Virol. 2011 Apr;85(8):4041-2. doi: 10.1128/JVI.00181-11. Epub 2011 Feb 9. No abstract available.

22.

Acute dengue virus 2 infection in Gabonese patients is associated with an early innate immune response, including strong interferon alpha production.

Becquart P, Wauquier N, Nkoghe D, Ndjoyi-Mbiguino A, Padilla C, Souris M, Leroy EM.

BMC Infect Dis. 2010 Dec 17;10:356. doi: 10.1186/1471-2334-10-356.

23.

Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis.

Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM.

PLoS Negl Trop Dis. 2010 Oct 5;4(10). pii: e837. doi: 10.1371/journal.pntd.0000837.

24.

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.

Wauquier N, Padilla C, Becquart P, Leroy E, Vieillard V.

Immunogenetics. 2010 Dec;62(11-12):767-71. doi: 10.1007/s00251-010-0480-x. Epub 2010 Sep 29.

25.

High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.

Becquart P, Wauquier N, Mahlakõiv T, Nkoghe D, Padilla C, Souris M, Ollomo B, Gonzalez JP, De Lamballerie X, Kazanji M, Leroy EM.

PLoS One. 2010 Feb 9;5(2):e9126. doi: 10.1371/journal.pone.0009126. Erratum in: PLoS One. 2010;5(2) doi: 10.1371/annotation/9bc62f9e-8386-4e9b-951c-1eeba930a41c.

26.

Emerging viral threats in Gabon: health capacities and response to the risk of emerging zoonotic diseases in Central Africa.

Bourgarel M, Wauquier N, Gonzalez JP.

Emerg Health Threats J. 2010;3:e7. doi: 10.3134/ehtj.10.163. Epub 2010 Jun 3.

27.

Immunoglobulin G in Ebola outbreak survivors, Gabon.

Wauquier N, Becquart P, Gasquet C, Leroy EM.

Emerg Infect Dis. 2009 Jul;15(7):1136-7. doi: 10.3201/eid1507.090402. No abstract available.

28.

NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.

Fausther-Bovendo H, Wauquier N, Cherfils-Vicini J, Cremer I, Debré P, Vieillard V.

AIDS. 2008 Jan 11;22(2):217-26.

PMID:
18097224

Supplemental Content

Loading ...
Support Center